DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Tesis de maestría (MasterThesis)
Monomeric C Reactive Protein and soluble Epoxide Hydrolase as novel targets for Alzheimer's disease therapy
Trabajo fin de máster presentado en la Universidad de Barcelona, Máster en Neurociencias.--Calificación: Excelente, Alzheimer’s Disease (AD) represents a serious problem for the public health due to the
increase in the life expectancy that rises the number of patients affected. After
ischemia or stroke, a high percent of patients develops ischemia. Inflammation in AD is
widely present and it is considered as a contributor to the cognitive loss and
neurodegeneration. Monomeric C reactive protein (mCRP) has been recently
described as a possible link between ischemia, inflammation and dementia.
Epoxyeicosatrienoic acids (EETs) have anti-inflammatory properties which disappear
when the soluble Epoxide Hydrolase (sEH) metabolizes them to sub-products. Thus,
inhibiting the sEH (with TPPU) or mCRP could be a potential target to treat AD. The
aim of this study was to evaluate both mCRP and sEH effects in C57BL6 mice and
compare them to a well-established AD mouse model: 5xFAD mice. Mice underwent
stereotaxic surgery to administrate mCRP at the hippocampus. Several behavioral
tests, Western Blot and RT-PCR analysis were done one month after surgery. mCRP
treated mice showed recognition memory and spatial memory loss. TPPU conferred
neuroprotection against cognitive loss, as well as an increase in synaptic plasticity. The
molecular pathways through which mCRP and TPPU act are still unclear and further
studies are planned. 5xFAD mice showed cognitive loss, amyloid pathology and
neuroinflammation, as expected.
Keywords:, This work was supported by grants SAF2016-75508 from the Spanish MINECO
and FEDER; 2017-SGR-106 from AGAUR and the CERCA Programme from
Generalitat de Catalunya
Proyecto:
MINECO SAF2016-75508